annual current liabilities:
$28.69B+$2.30B(+8.72%)Summary
- As of today (May 21, 2025), NVS annual total current liabilities is $28.69 billion, with the most recent change of +$2.30 billion (+8.72%) on December 31, 2024.
- During the last 3 years, NVS annual current liabilities has fallen by -$1.52 billion (-5.02%).
- NVS annual current liabilities is now -13.21% below its all-time high of $33.06 billion, reached on December 31, 2020.
Performance
NVS Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$31.62B+$2.93B(+10.20%)Summary
- As of today (May 21, 2025), NVS quarterly total current liabilities is $31.62 billion, with the most recent change of +$2.93 billion (+10.20%) on March 31, 2025.
- Over the past year, NVS quarterly current liabilities has increased by +$2.33 billion (+7.96%).
- NVS quarterly current liabilities is now -43.67% below its all-time high of $56.13 billion, reached on March 31, 2019.
Performance
NVS quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NVS Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.7% | +8.0% |
| 3 y3 years | -5.0% | +6.1% |
| 5 y5 years | +1.5% | +1.0% |
NVS Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.0% | +8.7% | -34.7% | +19.8% |
| 5 y | 5-year | -13.2% | +8.7% | -34.7% | +19.8% |
| alltime | all time | -13.2% | +297.8% | -43.7% | +338.4% |
NVS Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $31.62B(+10.2%) |
| Dec 2024 | $28.69B(+8.7%) | $28.69B(+2.0%) |
| Sep 2024 | - | $28.13B(+1.9%) |
| Jun 2024 | - | $27.61B(-5.7%) |
| Mar 2024 | - | $29.29B(+11.0%) |
| Dec 2023 | $26.39B(-7.9%) | $26.39B(-45.5%) |
| Sep 2023 | - | $48.39B(+51.7%) |
| Jun 2023 | - | $31.91B(+4.5%) |
| Mar 2023 | - | $30.55B(+6.6%) |
| Dec 2022 | $28.66B(-5.1%) | $28.66B(+1.8%) |
| Sep 2022 | - | $28.16B(+1.9%) |
| Jun 2022 | - | $27.65B(-7.2%) |
| Mar 2022 | - | $29.81B(-1.3%) |
| Dec 2021 | $30.21B(-8.6%) | $30.21B(+1.1%) |
| Sep 2021 | - | $29.88B(+0.8%) |
| Jun 2021 | - | $29.63B(-1.7%) |
| Mar 2021 | - | $30.16B(-8.8%) |
| Dec 2020 | $33.06B(+17.0%) | $33.06B(+3.8%) |
| Sep 2020 | - | $31.84B(+8.4%) |
| Jun 2020 | - | $29.38B(-6.1%) |
| Mar 2020 | - | $31.29B(+10.7%) |
| Dec 2019 | $28.26B(-4.5%) | $28.26B(+0.2%) |
| Sep 2019 | - | $28.22B(-6.3%) |
| Jun 2019 | - | $30.11B(-46.4%) |
| Mar 2019 | - | $56.13B(+89.6%) |
| Dec 2018 | $29.61B(+26.5%) | $29.61B(+4.5%) |
| Sep 2018 | - | $28.33B(+1.4%) |
| Jun 2018 | - | $27.94B(-1.0%) |
| Mar 2018 | - | $28.22B(+20.6%) |
| Dec 2017 | $23.40B(+5.4%) | $23.40B(-7.8%) |
| Sep 2017 | - | $25.38B(-2.9%) |
| Jun 2017 | - | $26.15B(-0.7%) |
| Mar 2017 | - | $26.33B(+18.6%) |
| Dec 2016 | $22.21B(-6.3%) | $22.21B(-9.7%) |
| Sep 2016 | - | $24.60B(-6.3%) |
| Jun 2016 | - | $26.27B(-5.6%) |
| Mar 2016 | - | $27.82B(+17.3%) |
| Dec 2015 | $23.71B(-12.1%) | $23.71B(-15.8%) |
| Sep 2015 | - | $28.16B(-4.2%) |
| Jun 2015 | - | $29.39B(+1.2%) |
| Mar 2015 | - | $29.05B(+7.7%) |
| Dec 2014 | $26.97B(+2.3%) | $26.97B(+1.3%) |
| Sep 2014 | - | $26.62B(-3.4%) |
| Jun 2014 | - | $27.56B(+11.3%) |
| Mar 2014 | - | $24.76B(-6.1%) |
| Dec 2013 | $26.37B(+9.6%) | $26.37B(+2.2%) |
| Sep 2013 | - | $25.81B(+5.8%) |
| Jun 2013 | - | $24.39B(-7.5%) |
| Mar 2013 | - | $26.37B(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $24.05B(+3.9%) | $24.05B(+10.0%) |
| Sep 2012 | - | $21.86B(-12.3%) |
| Jun 2012 | - | $24.92B(-8.9%) |
| Mar 2012 | - | $27.36B(+18.2%) |
| Dec 2011 | $23.15B(-6.1%) | $23.15B(-10.4%) |
| Sep 2011 | - | $25.83B(-12.5%) |
| Jun 2011 | - | $29.54B(-8.3%) |
| Mar 2011 | - | $32.22B(+30.7%) |
| Dec 2010 | $24.66B(+26.6%) | $24.66B(-10.8%) |
| Sep 2010 | - | $27.66B(+55.1%) |
| Jun 2010 | - | $17.83B(+2.3%) |
| Mar 2010 | - | $17.43B(-10.5%) |
| Dec 2009 | $19.47B(+18.0%) | $19.47B(+8.8%) |
| Sep 2009 | - | $17.90B(+16.6%) |
| Jun 2009 | - | $15.36B(+2.5%) |
| Mar 2009 | - | $14.99B(-9.2%) |
| Dec 2008 | $16.50B(-0.8%) | $16.50B(-17.3%) |
| Sep 2008 | - | $19.95B(+1.4%) |
| Jun 2008 | - | $19.68B(+15.4%) |
| Mar 2008 | - | $17.06B(+2.5%) |
| Dec 2007 | $16.64B(+2.5%) | $16.64B(-4.9%) |
| Sep 2007 | - | $17.50B(+9.5%) |
| Jun 2007 | - | $15.98B(-8.9%) |
| Mar 2007 | - | $17.55B(+8.1%) |
| Dec 2006 | $16.23B(+5.9%) | $16.23B(-0.5%) |
| Sep 2006 | - | $16.32B(-2.6%) |
| Jun 2006 | - | $16.76B(+7.5%) |
| Mar 2006 | - | $15.59B(+1.7%) |
| Dec 2005 | $15.33B(+29.4%) | $15.33B(+23.0%) |
| Sep 2005 | - | $12.46B(-1.5%) |
| Jun 2005 | - | $12.64B(+11.7%) |
| Mar 2005 | - | $11.32B(-4.4%) |
| Dec 2004 | $11.85B(+27.1%) | $11.85B(+31.9%) |
| Sep 2004 | - | $8.98B(-0.1%) |
| Jun 2004 | - | $8.99B(-4.6%) |
| Mar 2004 | - | $9.42B(+1.1%) |
| Dec 2003 | $9.32B(+12.7%) | $9.32B(+11.7%) |
| Sep 2003 | - | $8.35B(-15.0%) |
| Jun 2003 | - | $9.82B(+2.9%) |
| Mar 2003 | - | $9.54B(+15.3%) |
| Dec 2002 | $8.27B(-3.7%) | $8.27B(-0.1%) |
| Sep 2002 | - | $8.28B(+2.0%) |
| Jun 2002 | - | $8.12B(-5.5%) |
| Dec 2001 | $8.59B(+19.1%) | $8.59B(+5.6%) |
| Jun 2001 | - | $8.13B(+12.7%) |
| Dec 2000 | $7.21B(-34.0%) | $7.21B(-19.3%) |
| Jun 2000 | - | $8.94B |
| Dec 1999 | $10.93B(+0.4%) | - |
| Dec 1998 | $10.89B | - |
FAQ
- What is Novartis AG annual total current liabilities?
- What is the all time high annual current liabilities for Novartis AG?
- What is Novartis AG annual current liabilities year-on-year change?
- What is Novartis AG quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Novartis AG?
- What is Novartis AG quarterly current liabilities year-on-year change?
What is Novartis AG annual total current liabilities?
The current annual current liabilities of NVS is $28.69B
What is the all time high annual current liabilities for Novartis AG?
Novartis AG all-time high annual total current liabilities is $33.06B
What is Novartis AG annual current liabilities year-on-year change?
Over the past year, NVS annual total current liabilities has changed by +$2.30B (+8.72%)
What is Novartis AG quarterly total current liabilities?
The current quarterly current liabilities of NVS is $31.62B
What is the all time high quarterly current liabilities for Novartis AG?
Novartis AG all-time high quarterly total current liabilities is $56.13B
What is Novartis AG quarterly current liabilities year-on-year change?
Over the past year, NVS quarterly total current liabilities has changed by +$2.33B (+7.96%)